These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 29452143)

  • 1. Unusual Self-Assembly of the Recombinant Chlamydia trachomatis Major Outer Membrane Protein-Based Fusion Antigen CTH522 Into Protein Nanoparticles.
    Rose F; Karlsen K; Jensen PR; Jakobsen RU; Wood GK; Rand KD; Godiksen H; Andersen P; Follmann F; Foged C
    J Pharm Sci; 2018 Jun; 107(6):1690-1700. PubMed ID: 29452143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB/c mice model.
    Jiang P; Cai Y; Chen J; Ye X; Mao S; Zhu S; Xue X; Chen S; Zhang L
    Vaccine; 2017 May; 35(23):3096-3103. PubMed ID: 28456528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
    Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
    BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
    Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
    J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
    Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
    Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
    Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses induced by nano-self-assembled lipid adjuvants based on a monomycoloyl glycerol analogue after vaccination with the Chlamydia trachomatis major outer membrane protein.
    Rodrigues L; Raftopoulos KN; Tandrup Schmidt S; Schneider F; Dietz H; Rades T; Franzyk H; Pedersen AE; Papadakis CM; Christensen D; Winter G; Foged C; Hubert M
    J Control Release; 2018 Sep; 285():12-22. PubMed ID: 29964134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the disulfide bonds and free cysteine residues of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Yen TY; Pal S; de la Maza LM
    Biochemistry; 2005 Apr; 44(16):6250-6. PubMed ID: 15835913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation.
    Hepler RW; Nahas DD; Lucas B; Kaufhold R; Flynn JA; Galli JD; Swoyer R; Wagner JM; Espeseth AS; Joyce JG; Cook JC; Durr E
    Protein Sci; 2018 Nov; 27(11):1923-1941. PubMed ID: 30144190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface expression, single-channel analysis and membrane topology of recombinant Chlamydia trachomatis Major Outer Membrane Protein.
    Findlay HE; McClafferty H; Ashley RH
    BMC Microbiol; 2005 Jan; 5():5. PubMed ID: 15673471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Cai S; He F; Samra HS; de la Maza LM; Bottazzi ME; Joshi SB; Middaugh CR
    Mol Pharm; 2009; 6(5):1553-61. PubMed ID: 19650664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the Bam Complex Improves the Production of
    Huynh DT; Jong WSP; Koningstein GM; van Ulsen P; Luirink J
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice.
    Dixit S; Singh SR; Yilma AN; Agee RD; Taha M; Dennis VA
    Nanomedicine; 2014 Aug; 10(6):1311-21. PubMed ID: 24602605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free production of a functional oligomeric form of a
    He W; Felderman M; Evans AC; Geng J; Homan D; Bourguet F; Fischer NO; Li Y; Lam KS; Noy A; Xing L; Cheng RH; Rasley A; Blanchette CD; Kamrud K; Wang N; Gouvis H; Peterson TC; Hubby B; Coleman MA
    J Biol Chem; 2017 Sep; 292(36):15121-15132. PubMed ID: 28739800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.
    Zhu S; Feng Y; Rao P; Xue X; Chen S; Li W; Zhu G; Zhang L
    Appl Microbiol Biotechnol; 2014 May; 98(9):4107-17. PubMed ID: 24458565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human antibody signatures towards the Chlamydia trachomatis major outer membrane protein after natural infection and vaccination.
    Rosenkrands I; Olsen AW; Knudsen S; Dehari N; Juel HB; Cheeseman HM; Andersen P; Shattock RJ; Follmann F
    EBioMedicine; 2024 Jun; 104():105140. PubMed ID: 38744110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of
    Huynh DT; Nolfi E; Medfai L; van Ulsen P; Jong WSP; Sijts AJAM; Luirink J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2330768. PubMed ID: 38517203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.